Daily Filing Digest — 28 Aug 2026

A month-end Friday: 976 filings screened. The day's biggest news was a regulatory clearance, its most useful thread a split-screen on pricing power, and underneath, a steady run of capital-return, order and ownership filings. As always, everything below is checked against the primary document, and where a figure isn't disclosed or a filing is only procedural, we say so.

The big one

• Reliance / Jio Platforms — Reliance disclosed that SEBI has issued its observation letter on the draft prospectus for the Jio Platforms IPO — the regulatory step that clears the offering to proceed toward what would be one of India's largest-ever public issues. A landmark filing that the day's noise nearly buried.

The one to read first

• EPL, Kitex & Avanti — three companies, one cost shock, three answers. EPL passed the entire raw-material, freight and currency increase through and held its 18.8% margin; Kitex was downgraded as its EBITDA margin fell from 20.34% to 0.21% absorbing US tariffs it couldn't pass to five customers who are ~100% of its revenue; Avanti raised prices 10% and still bled, because the Andhra Pradesh government has a statutory "say in prices." What separates them isn't effort — it's who holds the price lever: Who Holds the Price Lever?.

Deals and restructuring

• Kronox Lab Sciences — an open offer by Indo Borax & Chemicals (with Zenrock Chemicals as PAC); the detailed public statement is out, offer price in that document.
• Power Grid — won 100% of the Fatehgarh-II transmission SPV under tariff-based competitive bidding. Patel Engineering — completed the sale of a 32% stake in ACP Tollways for ₹55 crore, a cash inflow.
• Foseco India — its MNC parent, Morgan Advanced Materials, is materially cutting its India holding: a promoter entity sold 7.84%, taking combined promoter holding from 15.27% to 7.43%.

Order wins

• KP Green Engineering — fresh confirmed orders of ₹258.02 crore (a separate entity from KPI Green Energy). ACME Solar — a 300 MW SECI FDRE-IX letter of award at ₹6.00/kWh on a 25-year PPA. KPI Green Energy — commissioned 200 MW at Khavda. VA Tech Wabag — told its AGM the order book now exceeds ₹17,200 crore.

Results

• JSW Cement — Q1 revenue ₹1,896 crore, up 21.6%, though EBITDA fell 7.5%; the company's presentation cites an 84% all-India share in GGBS (slag cement) — a genuine scale position. Patel Retail — Q1 revenue up 69.6% to ₹309.5 crore.

Capital actions

• Dividends: Ambika Cotton ₹37 (370%), Finolex Pipes (final + special), Biocon ₹0.50, and others. Fundraises: QIP allotments/closes at Gujarat Themis, UGRO Capital and Piramal Finance; Kalind approved ₹316 crore of convertible warrants to two non-promoter LLPs.

Ownership, pledges and control

• ICICI Prudential AMC — promoter Prudential sold 2% (holding 87.60% → 85.60%) in the open market, toward minimum-public-shareholding compliance.
• International Conveyors (INTLCONV) — promoter encumbrance jumped from 50.69% to 63.93%, the fresh pledge securing a third-party loan that part-finances an acquisition, with a disclosed security-cover ratio of zero — pledge leverage for non-operational use.
• Panorama Studios — a promoter pledge created over 6.27% of the company to Motilal Oswal. LCC Infotech — a 13.72% off-market share purchase. Groww (Ribbit) and Chambal Fertilisers (Earthstone) each saw substantial-acquirer (SAST) disclosures.

Management and regulatory

• TVS Motor — appointed Peyman Kargar as Director & CEO, effective 27 January 2027 — a notable top-of-house change at a bluechip. Ola Electric — its company secretary resigned.
• Aurobindo Pharma — a US FDA inspection at its Apitoria API unit (Unit-VI, Andhra Pradesh) closed with three Form-483 observations, described as procedural. Juniper Hotels — denied a media report of an FSSAI hygiene action.
• Distress: BKM Industries entered insolvency (CIRP); Madhucon Projects flagged it is not providing for interest pending a one-time settlement — a stress signal worth logging.

Educational research, not investment advice. Every figure above is drawn from the named company's own primary filing dated 28-Aug-2026 and checked against the source; where a value wasn't disclosed, none is stated. No buy/sell recommendations, no price targets. Moat & Margin is not a SEBI-registered Research Analyst or Investment Adviser.